Illumina Launches the NeoPrep Library Prep System
February 23 2015 - 6:30AM
Business Wire
Innovative Load-and-Go System Brings
High-Quality, Reproducible Library Prep to Any Lab
Illumina, Inc. (NASDAQ:ILMN) today announced the launch of the
NeoPrep™ Library Prep System, which greatly simplifies library
preparation and delivers high-quality sequencing-ready libraries
for next-generation sequencing (NGS). The newest addition to the
Illumina portfolio of NGS solutions consists of a NeoPrep desktop
instrument, disposable library cards, and reagents. Together with
Illumina sequencers and the BaseSpace® computing environment, the
new system plays an integral role in providing NGS users with the
easiest, most efficient and complete workflow.
NeoPrep Library Prep System (Photo:
Business Wire)
The NeoPrep System is the first commercially available product
that performs library prep, quantification and normalization, in a
single, self-contained instrument. Innovative digital microfluidics
technology decreases hands-on time from several hours to 30
minutes. By precisely manipulating droplets within the tightly
controlled library card environment, the system delivers reliable,
high-quality DNA and RNA libraries from starting amounts 4 to 10
times lower than those required for equivalent manual assays. By
creating 16 libraries per run, users can prepare up to 160
libraries per week, providing an affordable, walk-away solution
that simplifies lab processes, and reduces the need for ancillary
equipment and user-supplied reagents and consumables.
“Illumina is enabling the broadest-possible adoption of NGS
across research, clinical, and applied markets,” said Kirk Malloy,
Senior Vice President and General Manager of Illumina’s Life
Science Business. “The NeoPrep System is a key milestone in the
evolution of NGS technology. It makes NGS accessible to any lab by
radically simplifying the library preparation process, creating a
seamless workflow of Illumina solutions for library preparation,
sequencing, and data analysis. By continuing to drive adoption of
NGS, we aim to help our customers generate new discoveries and
applications in oncology, reproductive health, forensics,
microbiology, and other key markets.”
The NeoPrep System is designed for use with the Illumina
portfolio of library preparation kits, supporting the most commonly
used NGS applications on all Illumina sequencing systems. Each kit
includes the library card as well as all reagents required to
create NeoPrep libraries.
The NeoPrep System and NeoPrep versions of the TruSeq® Nano DNA
Kit and TruSeq Stranded mRNA Kit will begin shipping in March 2015.
Additional library preparation products will become available later
in the year, including NeoPrep versions of the TruSeq DNA PCR-Free
Kit and other targeted resequencing kits.
For more information, please visit
www.illumina.com/neoprepsystem.
About Illumina
Illumina is transforming human health as the global leader in
sequencing and array-based technologies. The company serves
customers in a broad range of markets, enabling the adoption of
genomic solutions in research and clinical settings. To learn how
Illumina is unlocking the power of the genome,
visit www.illumina.com and follow @illumina.
Forward-Looking Statements
This release contains forward-looking statements that involve
risks and uncertainties. Examples of forward-looking statements
include, but are not limited to, statements we make regarding the
expected availability dates for new products and services and FDA
submission dates and intentions for certain products and services.
Important factors that could cause actual results to differ
materially from those in any forward-looking statements include
challenges inherent in developing, manufacturing, and launching new
products and services and the other factors that are detailed in
our filings with the Securities and Exchange Commission, including
our most recent filings on Forms 10-K and 10-Q, or in information
disclosed in public conference calls, the date and time of which
are released beforehand. We do not intend to update any
forward-looking statements after the date of this release.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20150223005171/en/
Illumina, Inc.Investors:Rebecca
Chambers858-255-5243rchambers@illumina.comorMedia:Jennifer
Temple858-882-6822pr@illumina.com
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Apr 2024 to May 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From May 2023 to May 2024